Aethlon Medical Statistics Share Statistics Aethlon Medical has 2.59M
shares outstanding. The number of shares has increased by 3.7%
in one year.
Shares Outstanding 2.59M Shares Change (YoY) 3.7% Shares Change (QoQ) -0.04% Owned by Institutions (%) 24.23% Shares Floating 2.48M Failed to Deliver (FTD) Shares 4,499 FTD / Avg. Volume 1.7%
Short Selling Information The latest short interest is 229.56K, so 11.42% of the outstanding
shares have been sold short.
Short Interest 229.56K Short % of Shares Out 11.42% Short % of Float 11.53% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.33 and the forward
PE ratio is -0.61.
Aethlon Medical's PEG ratio is
0.
PE Ratio -0.33 Forward PE -0.61 PS Ratio 0 Forward PS 0 PB Ratio 0.87 P/FCF Ratio -0.58 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Aethlon Medical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.13,
with a Debt / Equity ratio of 0.13.
Current Ratio 3.13 Quick Ratio 3.13 Debt / Equity 0.13 Debt / EBITDA -0.05 Debt / FCF -0.08 Interest Coverage -924.06
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-956.29K Employee Count 14 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -50.8% in the
last 52 weeks. The beta is 1.72, so Aethlon Medical's
price volatility has been higher than the market average.
Beta 1.72 52-Week Price Change -50.8% 50-Day Moving Average 1.62 200-Day Moving Average 3.26 Relative Strength Index (RSI) 43.15 Average Volume (20 Days) 265,198
Income Statement
Revenue n/a Gross Profit n/a Operating Income -9.34M Net Income -13.39M EBITDA -13.04M EBIT -13.38M Earnings Per Share (EPS) -8.58
Full Income Statement Balance Sheet The company has 5.5M in cash and 649.75K in
debt, giving a net cash position of 4.85M.
Cash & Cash Equivalents 5.5M Total Debt 649.75K Net Cash 4.85M Retained Earnings -167.95M Total Assets 7.36M Working Capital 4.05M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.65M
and capital expenditures 0, giving a free cash flow of -7.65M.
Operating Cash Flow -7.65M Capital Expenditures n/a Free Cash Flow -7.65M FCF Per Share -4.9
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields AEMD does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for AEMD is $1.5,
which is 22% higher than the current price. The consensus rating is "Hold".
Price Target $1.5 Price Target Difference 22% Analyst Consensus Hold Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 9, 2025. It was a
backward
split with a ratio of 1:8.
Last Split Date Jun 9, 2025 Split Type backward Split Ratio 1:8
Scores Altman Z-Score -30.44 Piotroski F-Score 2
